MEDIROM Healthcare Technologies Inc. (MRM)
NASDAQ: MRM · Real-Time Price · USD
0.9907
-0.0143 (-1.42%)
At close: Aug 21, 2026, 4:00 PM EDT
0.9000
-0.0907 (-9.16%)
After-hours: Aug 21, 2026, 6:34 PM EDT
MRM Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 7,885 | 604.53 | 8,146 | 6,628 | 6,560 | 5,366 |
Other Revenue | 181.89 | - | 153.63 | 200.4 | 393.77 | 43.97 |
| 8,067 | 604.53 | 8,299 | 6,828 | 6,954 | 5,410 | |
Revenue Growth | 12.79% | -92.72% | 21.55% | -1.81% | 28.54% | 61.89% |
Cost of Revenue | 6,046 | 5.73 | 6,053 | 5,259 | 5,052 | 3,994 |
Gross Profit | 2,021 | 598.8 | 2,246 | 1,569 | 1,902 | 1,415 |
Selling, General & Admin | 2,218 | - | 2,242 | 1,960 | 1,805 | 1,811 |
Other Operating Expenses | - | 536.82 | - | - | - | - |
Operating Expenses | 2,218 | 536.82 | 2,242 | 1,960 | 1,805 | 1,811 |
Operating Income | -196.75 | 61.98 | 4.77 | -391.58 | 96.97 | -395.38 |
Interest Expense | -55.13 | -57.6 | -49.75 | -36.87 | -9.8 | -11.95 |
Interest & Investment Income | 0.06 | - | 0.01 | 1.11 | 6.07 | 0.84 |
Currency Exchange Gain (Loss) | 18.12 | - | 18.12 | 26.83 | 14.83 | 14.99 |
Other Non Operating Income (Expenses) | 118.6 | 52.46 | 56.8 | 7.45 | 71.7 | 52.22 |
EBT Excluding Unusual Items | -115.1 | 56.83 | 29.95 | -393.06 | 179.77 | -339.27 |
Merger & Restructuring Charges | - | - | - | - | - | -12 |
Gain (Loss) on Sale of Assets | 164.2 | - | 40.63 | 413.68 | - | - |
Asset Writedown | -107.46 | - | -22.87 | - | - | -63.21 |
Pretax Income | -58.35 | 56.83 | 47.71 | 20.62 | 179.77 | -414.48 |
Income Tax Expense | -93.95 | 0.78 | -90.48 | -94.43 | 30.81 | 576.25 |
Earnings From Continuing Operations | 35.6 | 56.06 | 138.19 | 115.05 | 148.97 | -990.73 |
Net Income to Company | - | - | 138.19 | 115.05 | 148.97 | -990.73 |
Minority Interest in Earnings | 4.87 | - | 10.57 | 0.36 | - | - |
Net Income | 40.47 | 56.06 | 148.76 | 115.4 | 148.97 | -990.73 |
Net Income to Common | 40.47 | 56.06 | 148.76 | 115.4 | 148.97 | -990.73 |
Net Income Growth | - | -62.32% | 28.91% | -22.53% | - | - |
Shares Outstanding (Basic) | 7 | - | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 7 | - | 6 | 5 | 5 | 5 |
Shares Change | 50.05% | - | 13.26% | -5.56% | 12.16% | 21.19% |
EPS (Basic) | 6.13 | - | 29.13 | 23.64 | 30.54 | -203.13 |
EPS (Diluted) | 6.13 | - | 28.52 | 22.34 | 27.23 | -203.13 |
EPS Growth | - | - | 27.65% | -17.96% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -967.07 | - | -1,403 | -767.58 | -806.44 | -652.88 |
Free Cash Flow Per Share | -131.62 | - | -239.78 | -148.56 | -147.41 | -133.86 |
Gross Margin | 25.05% | 99.05% | 27.07% | 22.98% | 27.36% | 26.16% |
Operating Margin | -2.44% | 10.25% | 0.06% | -5.73% | 1.39% | -7.31% |
Profit Margin | 0.50% | 9.27% | 1.79% | 1.69% | 2.14% | -18.31% |
Free Cash Flow Margin | -11.99% | - | -16.91% | -11.24% | -11.60% | -12.07% |
EBITDA | 149.08 | - | 294.81 | -138.98 | 281.02 | -269.13 |
EBITDA Margin | 1.85% | - | 3.55% | -2.04% | 4.04% | -4.98% |
D&A For EBITDA | 345.83 | - | 290.04 | 252.6 | 184.06 | 126.24 |
EBIT | -196.75 | 61.98 | 4.77 | -391.58 | 96.97 | -395.38 |
EBIT Margin | -2.44% | 10.25% | 0.06% | -5.73% | 1.39% | -7.31% |
Effective Tax Rate | - | - | - | - | 17.14% | - |
Revenue as Reported | 8,067 | - | 8,299 | 6,828 | 6,954 | 5,410 |
Advertising Expenses | - | - | 155.36 | 162.03 | 135.13 | 130.96 |